Breaking News

Sports News, Announcements, and Job Opportunities in the Mid-Ohio Valley Registration deadlines for fall youth sports programs at Bend Park and Rec approaching REWE Group Renews Contract for Director of Digital and Technology Sky rookie Angel Reese emotional after receiving first All-Star selection Steve Kerr makes changes to Warriors coaching staff, adds two new members – NBC Sports Bay Area & California

The Centers for Disease Control and Prevention (CDC) have recently issued a new guideline that recommends taking an antibiotic as a morning-after pill to prevent certain sexually transmitted diseases. Specifically, taking doxycycline after unprotected sex has been endorsed as a way to prevent chlamydia, gonorrhea, or syphilis infections. This new recommendation is aimed at gay and bisexual men and transgender women who have had an STD in the previous year and are at high risk of getting infected again.

The CDC officials have called this the first new prevention tool against sexually transmitted infections in decades, highlighting the need for innovation in this area. Rates of syphilis, chlamydia, and gonorrhea have been on the rise for years, especially among gay and bisexual men. However, the latest data suggests that cases of chlamydia and gonorrhea stopped rising in 2022.

The treatment recommended by CDC officials is called doxycycline postexposure prophylaxis (doxy PEP). Doctors can prescribe a single dose of 200 milligrams of doxycycline to be taken within three days of unprotected sex. The guideline is specific to certain at-risk groups, and more evidence is needed to make the same recommendation for other populations.

In October, the CDC released a draft version of the guidelines and made some changes based on public feedback. The finalized guideline emphasizes that the pills should be taken only once per 24 hours and that doctors should reassess the regimen with patients every three to six months. The aim of this new prevention tool is to help reduce the spread of sexually transmitted infections and improve overall public health.

Overall, this new recommendation marks an important step towards preventing STIs among those who are most at risk. By providing a new tool for prevention, it’s hoped that rates of these diseases will continue to decline over time.

It’s worth noting that while doxycycline postexposure prophylaxis (doxy PEP) has been shown effective against some STIs such as chlamydia, gonorrhea or syphilis, it’s not always necessary or appropriate for everyone who has had unprotected sex. It’s important for individuals to consult with their healthcare provider before taking any medication.

Additionally, it’s crucial to remember that preventing STIs involves more than just taking medication after-the-fact; it also requires practicing safe sexual behavior such as using protection during intercourse and getting regular screenings for STIs.

In conclusion, while this new guideline represents a significant advancement in STI prevention efforts among certain populations

Leave a Reply